A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2011
10/20/2011	WO2011047390A3 Heterocyclic benzoxazole compositions as inhibitors of hepatitis c virus
10/20/2011	WO2011046905A3 Pharmaceutical compositions
10/20/2011	WO2011038157A3 Zinc-containing compositions for the treatment of diseases, illnesses and syndromes associated with exposure to pore forming toxins
10/20/2011	US20110257623 Implantable medical devices having microporous surface layers and method for reducing foreign body response to the same
10/20/2011	US20110257586 Calciumphosphate-based nanoparticles as carrier-systems for photodynamic therapy
10/20/2011	US20110257583 Thiadiazole Compounds and Uses Thereof
10/20/2011	US20110257364 Process for purifying glycopeptide phosphonate derivatives
10/20/2011	US20110257264 Use of 2,5-dihydroxybenzene derivatives for treating actinic keratosis
10/20/2011	US20110257258 Method for Preventing and Treating Avian Influenza in Human
10/20/2011	US20110257233 Benzoisothiazolones as inhibitors of phosphomannose isomerase
10/20/2011	US20110257222 Compounds and methods for the treatment of pain and other diseases
10/20/2011	US20110257204 Penciclovir or Famciclovir for Treatment of Recurrent Genital Herpes with a One-Day Application
10/20/2011	US20110257197 Pharmaceutical Formulations Comprising Voriconazole and Processes for Preparation Thereof
10/20/2011	US20110257192 Compound for treatment of respiratory condition or disease
10/20/2011	US20110257178 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
10/20/2011	US20110257176 Nitrogen heterocycle derivatives as proteasome modulators
10/20/2011	US20110257162 Hiv integrase inhibitors
10/20/2011	US20110257154 Compounds and compositions as protein kinase inhibitors
10/20/2011	US20110257144 Novel dermaceutical cream made using sodium fusidate
10/20/2011	US20110257139 Treatment of diarrhoea
10/20/2011	US20110257132 Charged phospholipid compositions and methods for their use
10/20/2011	US20110257129 Enantiomerically pure phosphoindoles as hiv inhibitors
10/20/2011	US20110257122 Nucleoside phosphoramidate prodrugs
10/20/2011	US20110257121 Purine nucleoside phosphoramidate
10/20/2011	US20110257120 Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis b
10/20/2011	US20110257111 Hydroxyethlamino Sulfonamide Derivatives
10/20/2011	US20110257105 Synthetic peptide amides and dimers thereof
10/20/2011	US20110257094 Anti periodontitis-causing microorganism agent and medical or dental materials using the same
10/20/2011	US20110257082 Hiv-1 integrase derived stimulatory peptides interfering with integrase -- rev protein binding
10/20/2011	US20110257081 Multigand constructs
10/20/2011	US20110257080 Hepatitis B Virus Compositions and Methods of Use
10/20/2011	US20110257079 Parenteral Combination Therapy for Infective Conditions With Drug Resistant Bacterium
10/20/2011	US20110257078 Antibacterial combination therapy for the treatment of gram positive bacterial infections
10/20/2011	US20110256625 Liver Engrafting Cells, Assays, and Uses Thereof
10/20/2011	US20110256232 Antimicrobial composition from copepods
10/20/2011	US20110256224 Methods and compositions for targeted delivery
10/20/2011	US20110256214 Single-time vaccines
10/20/2011	US20110256213 Phospholipid micellar and liposomal compositions and uses thereof
10/20/2011	US20110256206 Implantable devices for treating hiv
10/20/2011	US20110256188 Dry powder pharmaceutical composition for inhalation
10/20/2011	US20110256187 Biofilm-inhibitory coatings that release salicyclic acid by hydrolisis
10/20/2011	US20110256185 Reinforced tissue shields
10/20/2011	US20110256180 Factor H Binding Proteins (FHBP) with Altered Properties and Methods of Use Thereof
10/20/2011	US20110256179 Pharmaceutical preparation comprising a combination of streptococcus strains and lactobacillus strains
10/20/2011	US20110256178 Borrellia burgdorferi bacterin
10/20/2011	US20110256177 Yersinia pestis vaccine
10/20/2011	US20110256176 Herpes simplex virus combined subunit vaccines and methods of use thereof
10/20/2011	US20110256175 Amino lipids and methods for the delivery of nucleic acids
10/20/2011	US20110256174 Rabies vaccine
10/20/2011	US20110256173 Chemical synthesis of phosphatidylinositol mannoside glycans from mycobacterium tuberculosis
10/20/2011	US20110256172 Epitope-targeted anthrax vaccine
10/20/2011	US20110256166 Multivalent vaccines comprising recombinant viral vectors
10/20/2011	US20110256165 Compositions of hsp60 peptides and viral antigens for vaccination and diagnosis
10/20/2011	US20110256161 Methods for enhancing immune response
10/20/2011	US20110256151 Antibodies to human il-1beta
10/20/2011	US20110256141 Monoclonal Antibodies Specific to the Fusion Peptide From Hemagglutinin From Influenza A Viruses and Uses Thereof
10/20/2011	US20110256140 Anti-hcv monoclonal antibody as a medicament for the theraputic treatment and prevention of hcv infections
10/20/2011	US20110256132 Myostatin binding proteins
10/20/2011	US20110256131 BLOCKERS OF LIGHT, LTalpha1beta2 AND LTalpha2beta1 OR ITS RECEPTOR LTbetaR FOR THE PREVENTION AND TREATMENT OF CHRONIC HEPATITIS AND OTHER LIVER DISEASES
10/20/2011	US20110256126 IL-17A/F Heterologous Polypeptides and Therapeutic Uses Thereof
10/20/2011	US20110256118 Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals
10/20/2011	US20110256117 Manufacturing and use of composite scaffolds
10/20/2011	US20110256116 Low/High Dose Probiotic Supplements And Methods Of Their Use
10/20/2011	US20110256115 Hydrosoluble [6)o-alpha-d-glcp-(1->]n-6-o-beta-d-glcp-(1->-phenolic derivatives with dermocosmetic, nutritional and therapeutic applications, and compositions containing said water soluble compounds
10/20/2011	US20110256104 Complexing agents for compositions containing inclusion complexes
10/20/2011	US20110256103 method of producing a pharmacologically stable form of lyophilised, active preparations of purified bacteriophages
10/20/2011	US20110256099 Compounds for the Treatment of Hepatitis C
10/20/2011	US20110256098 Immunotherapy for chronic hepatitis c virus infection
10/20/2011	US20110256097 Treatment of Conditions that Increase in Severity and/or Occurrence During One or More Phases of the Menstrual Cycle
10/20/2011	US20110256094 Methods and Compositions for Chlamydial Antigens for Diagnosis and Treatment of Chlamydial Infection and Disease
10/20/2011	US20110256073 Formulations for treating and/or preventing Black-Line Stains
10/20/2011	US20110256070 Pharmaceutical compositions and methods for administering the same
10/20/2011	CA2796243A1 Combination of a macrocyclic inhibitor of hcv, a non-nucleoside and a nucleoside
10/20/2011	CA2796207A1 Compound for treatment of respiratory condition or disease
10/20/2011	CA2796068A1 Anti-bacterial applications of poly-n-acetylglucosamine nanofibers
10/20/2011	CA2795953A1 Antibodies for the treatment of clostridium difficile-associated infection and disease
10/19/2011	EP2377885A1 Method for producing comprehensive anti-surface antibody wherein the antigen used is a microorganism fixed by a protein crosslinking and fixation reagent
10/19/2011	EP2377854A1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis C virus (HCV) inhibitors
10/19/2011	EP2377579A1 Cyclic peptide CXCR4 antagonists
10/19/2011	EP2377549A1 Use of IL-21 for treating viral infections
10/19/2011	EP2377547A1 Use of IL-21 as an antimicrobial agent
10/19/2011	EP2377545A1 Antibacterial agent for periodontal disease-causing bacteria, and medical or dental material using same
10/19/2011	EP2377543A2 Ophthalmic, pharmaceutical and other healthcare preparations with naturally ocurring plant compounds, extracts and derivatives
10/19/2011	EP2377400A1 Antibacterial composition and antiviral composition each containing silicon-containing compound, antibacterializing method, cleaning/mouth cleaning method, and method for immobilizing antibacterial agent or antiviral agent
10/19/2011	EP2376646A2 Process for purifying vancomycin wet body
10/19/2011	EP2376618A1 Compositions and methods for controlling disease in animals
10/19/2011	EP2376526A1 Modified streptococcus pneumoniae pneumolysin (ply) polypeptides
10/19/2011	EP2376515A1 Synthesis of purine nucleosides
10/19/2011	EP2376502A1 Thiazolopyridine sirtuin modulating compounds
10/19/2011	EP2376497A1 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives
10/19/2011	EP2376488A1 2- (piperidin-1-yl) -4-heterocyclyl-thiazole-5-carboxylic acid derivatives against bacterial infections
10/19/2011	EP2376483A1 Polymorph ii of an antifungal compound
10/19/2011	EP2376482A1 Substituted (thiophenyl-carbonyl)imidazolidinones, and use thereof
10/19/2011	EP2376435A2 Synergistic fungicidal compositions including hydrazone derivatives and copper
10/19/2011	EP2376433A1 Crystalline form c of tigecycline dihydrochloride and methods for its preparation
10/19/2011	EP2376431A1 Novel substituted aryl derivatives, their process of preparation and their therapeutical uses as anti-hiv agents
10/19/2011	EP2376196A1 Animal treatment formulation and methods of use
10/19/2011	EP2376119A1 Anti-hcv monoclonal antibody as a medicament for the therapeutic treatment and prevention of hcv infections
10/19/2011	EP2376114A2 Mixing lyophilised meningococcal vaccines with non-hib vaccines
10/19/2011	EP2376113A1 Compositions and dosage regimes comprising a clostridial vaccine and levamisole

1 ... 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 ... 1798